Kelly FitzGerald, PhD, CIP
IRB Executive Chair and VP IBC Affairs
Biography
Kelly FitzGerald, PhD, CIP, IRB executive chair and vice president IBC affairs, WCG, is responsible for the compliant and efficient operation of both the IRB and IBC. Kelly is a certified IRB professional (CIP) and holds a B.S. in Chemical Engineering from the University of New Hampshire and a PhD in Chemical Engineering from the University of Washington. Her graduate training was in genetic engineering, which led to an interest in medical diagnostic device technology. Prior to joining WCG in 2014, she worked in general research administration and invention licensing at the University of Washington for over 10 years.
Latest insights by Kelly
Series: WCG Talks Trials
Have a Safe Trip: Clinical and Patient Alignment in Research with Psychedelics
Podcasts
Ethics in Clinical Research
WCG’s Philosophy of Ethical Review
Blog Posts
Regulatory Compliance
How WCG Is Preparing for FDA Harmonization with the Common Rule
Blog PostsDiversity & Inclusion with Technology in Decentralized Trials
Podcasts
Ethics in Clinical Research
Delve into the World of Psychedelic Research and Ethical Inquiry
Podcasts
Ethics in Clinical Research
Research and Cannabis: Ethical Research in a Changing Regulatory Landscape
Whitepapers
Ethics in Clinical Research
What Can Institutions with Local IRBs Do to Prepare for the Proposed FDA Single IRB Mandate?
Whitepapers
Ethics in Clinical Research
What Can Institutions with Local IRBs Do to Prepare for the Proposed FDA Single IRB Mandate?
Whitepapers
Regulatory Compliance
What are the IRB review requirements for human factors/usability testing?
Blog Posts
FDA & ICH